Menu
Back to User profile » Dr Dmitry Sychev
Papers published by Dr Dmitry Sychev:
Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects
Dorofeeva MN, Shikh EV, Sizova ZM, Tarasenko AV, Denisenko NP, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA, Sychev DA
Pharmacogenomics and Personalized Medicine 2019, 12:329-339
Published Date: 5 November 2019
Pharmacogenetics of alcohol addiction: current perspectives
Zastrozhin MS, Skryabin VY, Miroshkin SS, Bryun EA, Sychev DA
The Application of Clinical Genetics 2019, 12:131-140
Published Date: 11 July 2019
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum]
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T
Pharmacogenomics and Personalized Medicine 2018, 11:167-168
Published Date: 26 September 2018
Effects of ABCB1 rs1045642 polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I–II hypertension
Sychev D, Shikh N, Morozova T, Grishina E, Ryzhikova K, Malova E
Pharmacogenomics and Personalized Medicine 2018, 11:157-165
Published Date: 20 September 2018
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T
Pharmacogenomics and Personalized Medicine 2018, 11:127-137
Published Date: 25 July 2018
CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
Denisenko NP, Sychev DA, Sizova ZM, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA
Pharmacogenomics and Personalized Medicine 2018, 11:107-112
Published Date: 18 June 2018
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke
Kryukov AV, Sychev DA, Andreev DA, Ryzhikova KA, Grishina EA, Ryabova AV, Loskutnikov MA, Smirnov VV, Konova OD, Matsneva IA, Bochkov PO
Pharmacogenomics and Personalized Medicine 2018, 11:43-49
Published Date: 22 March 2018
The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction
Zastrozhin MS, Grishina EA, Ryzhikova KA, Smirnov VV, Savchenko LM, Bryun EA, Sychev DA
Pharmacogenomics and Personalized Medicine 2018, 11:1-5
Published Date: 28 December 2017
Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients
Denisenko NP, Sychev DA, Sizova ZM, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA
Pharmacogenomics and Personalized Medicine 2017, 10:253-259
Published Date: 27 September 2017
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
Rytkin E, Mirzaev KB, Grishina EA, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Giliarov MI, Andreev DA, Sychev DA
Pharmacogenomics and Personalized Medicine 2017, 10:243-245
Published Date: 18 September 2017
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder
Zastrozhin MS, Brodyansky VM, Skryabin VY, Grishina EA, Ivashchenko DV, Ryzhikova KA, Savchenko LM, Kibitov AO, Bryun EA, Sychev DA
Pharmacogenomics and Personalized Medicine 2017, 10:209-215
Published Date: 7 July 2017
CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome
Mirzaev KB, Zelenskaya EM, Barbarash OL, Ganyukov VI, Apartsin KA, Saraeva NO, Nikolaev KY, Ryzhikova KA, Lifshits GI, Sychev DA
Pharmacogenomics and Personalized Medicine 2017, 10:107-114
Published Date: 12 April 2017
Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
Sychev DA, Shuev GN, Suleymanov SS, Ryzhikova KA, Mirzaev KB, Grishina EA, Snalina NE, Sozaeva ZA, Grabuzdov AM, Matsneva IA
Pharmacogenomics and Personalized Medicine 2017, 10:93-99
Published Date: 31 March 2017